Matthew Mintz and Merrill Goozner comment on the implications of this.
The FDA is considering lifting restrictions for off-label drug promotion
Real physician voices, twice a week
Free, and one click to unsubscribe.
More in Uncategorized
The Podcast
Latest episodes
Diagnosing the data: Applying clinical rigor to AI adoption
Why more medicine isn’t making us healthier
Amazon and Uber set the bar that primary care is judged against
Why patients stop trusting doctors who listened to them
Some relationships work like medicine. Others work like a diagnosis.
Food allergies are treated differently, airline by airline
Staying salaried may now be the riskier bet for doctors
Doctors’ kids miss them, and the family builds its own fixes
Why exhaustion can make you see things that aren’t there
Making AI work for physicians
